Archives

In the biggest deal of the company’s 120-year history, medical device giant Becton, Dickinson & Company has announced its acquisition of C.R. Bard for $24 billion. The cash and stock deal will see Bard shareholders receive $222.93 in cash and 0.5077 shares of Becton Dickinson stock per Bard share, or $317 per Bard share based on Becton Dickinson’s closing price of $185.29. The acquisition means Becton Dickinson’s portfolio, currently comprising syringes and… Read More
Category: Blog, Mergers and Acquisitions Tags: Acquisitions, Becton, Benchmark International, C.R. Bard, CareFusion Corp, Deal completions, Deal Making, deals, Medical Device, Medical Industry, Medical Sector, Medical Technology, Medical Technology Sector, mergers, Mergers and Acquisitions, US M&A, USA, Vincent Forlenza